Literature DB >> 29490886

Osteosarcoma of the jaw: Challenges in the diagnosis and treatment.

Mohamed Atef ElKordy1, Tarek Sherif ElBaradie2, Hisham Ismael ElSebai2, Sheriff Mohamed KhairAlla2, Ayman Abd ElWahab Amin2.   

Abstract

PURPOSE: Osteosarcomas rarely affect jaw bones. Patients are usually older than those who suffer long bone sarcomas, with a rare incidence of metastasis. This is suggestive of a different pattern of behavior compared with long bone sarcomas. This study aimed to present NCI, Cairo University experience in treating patients diagnosed with osteosarcomas of the jaw, including the diagnostic challenges and treatment outcome. PATIENTS AND METHODS: This is a retrospective case series study of all cases of osteosarcomas of mandible and maxilla that were treated at the NCI, in the period between 2006 and 2013. Patients' data, including demographic data, various clinical presentations, results of investigations, treatment modalities performed and outcomes, were collected from hospital records kept in the Biostatistics Department at NCI.
RESULTS: Records showed 21 cases of osteosarcoma of the jaw. The mandible was affected in 15 cases, the maxilla in six. Two cases had sun-ray periosteal reactions. Erroneous biopsy results were found in 4 cases compared with final pathology reports of surgical resections. All cases underwent surgical resections, with 8 cases having positive margins. The median follow-up period was 19.3 months (range 0.3-98.0 months). The cumulative disease-free survival (DFS) was 27.5% and the median DFS was 72 months. The cumulative overall survival at end of the study was 77.4%.
CONCLUSIONS: Osteosarcoma of the jaw is challenging both to diagnose and manage. This is due to the high incidence of mistakes in biopsy results, rare specific radiological features and difficulties in proper resection due to proximity to vital structures.
Copyright © 2018 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone tumors; Jaw; Mandible; Maxilla; Osteosarcoma

Mesh:

Year:  2018        PMID: 29490886     DOI: 10.1016/j.jnci.2018.02.001

Source DB:  PubMed          Journal:  J Egypt Natl Canc Inst        ISSN: 1110-0362


  15 in total

1.  [MiR-671-5p negatively regulates SMAD3 to inhibit migration and invasion of osteosarcoma cells].

Authors:  Y Hu; D Liang; X Chen; L Chen; J Bai; H Li; C Yin; W Zhong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-10-20

Review 2.  Intraosseous Venous Malformations of the Head and Neck.

Authors:  S B Strauss; J M Steinklein; C D Phillips; D R Shatzkes
Journal:  AJNR Am J Neuroradiol       Date:  2022-07-21       Impact factor: 4.966

3.  LncRNA UCA1 accelerates osteosarcoma progression via miR-145 and Wnt/β-catenin pathway.

Authors:  Jian Guan; Juliang He; Shian Liao; Zhenjie Wu; Xiang Lin; Bin Liu; Xiong Qin; Jiachang Tan; Chuangming Huang; Zhenchao Yuan; Hao Mo
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

4.  LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway.

Authors:  Weitao Yao; Jingyu Hou; Guoqing Liu; Fangxing Wu; Qiang Yan; Liangyu Guo; Chuchu Wang
Journal:  Mol Ther Oncolytics       Date:  2022-03-08       Impact factor: 6.311

Review 5.  Soft Tissue Special Issue: Imaging of Bone and Soft Tissue Sarcomas in the Head and Neck.

Authors:  Ngoc-Anh Tran; Jeffrey P Guenette; Jyothi Jagannathan
Journal:  Head Neck Pathol       Date:  2020-01-16

6.  The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway.

Authors:  Shenyu Wang; Gongyin Zhao; Shujie Zhao; Yusen Qiao; Huilin Yang
Journal:  Med Sci Monit       Date:  2020-04-21

7.  Effectiveness of electrical stimulation for postoperative pain in patients with osteosarcoma: A systematic review protocol of clinical controlled trial.

Authors:  Tao Yu; Hua-Yu Tang; Tian-Shu Wang; Wei Wei
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

8.  The Clinical Significance and Potential Molecular Mechanism of Upregulated CDC28 Protein Kinase Regulatory Subunit 1B in Osteosarcoma.

Authors:  Chaohua Mo; Le Xie; Chang Chen; Jie Ma; Yingxin Huang; Yanxing Wu; Yuanyuan Xu; Huizhi Peng; Zengwei Chen; Rongjun Mao
Journal:  J Oncol       Date:  2021-12-10       Impact factor: 4.375

9.  CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through β-catenin.

Authors:  Mingxin Wen; Hui Ren; Shouqiang Zhang; Tao Li; Jiefeng Zhang; Peng Ren
Journal:  Cell Death Dis       Date:  2021-06-25       Impact factor: 8.469

10.  Classification of Osteosarcoma Based on Immunogenomic Profiling.

Authors:  Xinwen Wang; Liangming Wang; Weifeng Xu; Xinwu Wang; Dianshan Ke; Jinluan Lin; Wanzun Lin; Xiaochun Bai
Journal:  Front Cell Dev Biol       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.